Analyze Diet

Apparent ELISA detection times for albuterol after administration with the torpex equine inhaler device.

Abstract: Single doses of one, three, and six actuations (120 micro g albuterol/actuation) and multiple daily doses (six actuations per dose four times daily) for 5 days of aerosol albuterol sulfate were sequentially administered to each of six horses using an equine inhaler device (Torpex, 3M Animal Care Products, St. Paul, MN [corrected] and Boehringer Ingleheim Vetmedica, Inc., St. Joseph, MO [corrected]). A 2-week washout period was allowed between each dose. ELISA testing revealed no evidence of albuterol in urine at 24 hours after any single-dose administration. Results indicated that 48 hours or longer should be allowed for albuterol to be cleared from urine after single doses. When given at the maximum recommended rate of six actuations per dose four times a day for 5 days, urine samples tested by ELISA showed no evidence of albuterol at 48 hours after the final dose. Testing of nasal swabs by ELISA demonstrated the presence of albuterol for 8 hours after each single dose, and some horses might have detectable levels of albuterol in nasal swabs for several days following administration of multiple doses. As a guideline for withdrawal time, 72 hours or longer should be allowed after administration of aerosol albuterol sulfate to horses before participation in equestrian competitions that are regulated for detection of certain performance-enhancing substances. However, these recommendations were based on a small sample of horses and the specific ELISA test used and interpreted as described. Factors specific to individual horses may influence these detection times.
Publication Date: 2002-11-26 PubMed ID: 12447838
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Clinical Trial
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article analyses the detection times of the asthma medication albuterol in horses after it was administered through an inhaler device. The study found that after single or multiple doses, albuterol could not be detected in urine 24-48 hours after administration. However, it was traceable in nasal swabs for several days, leading to a recommendation for a withdrawal time of at least 72 hours before competition.

Research Methodology

  • Albuterol sulfate was administered to six horses using an equine inhaler device, with single doses of one, three, and six actuations.
  • The doses were given sequentially, allowing a 2-week washout period between each dose, and multiple doses were given four times per day for 5 days.
  • The researchers used Enzyme-linked immunosorbent assay (ELISA) testing to detect albuterol levels in the urine and nasal swabs of the horses after administration. ELISA is a widely-used method for detecting substances in biological samples.

Results

  • The results suggested that albuterol was not detectable in urine 24 hours after single doses, indicating that 48 hours or longer should be allowed for albuterol to be cleared from urine.
  • When given at the maximum recommended rate of six actuations per dose four times a day for 5 days, urine samples showed no evidence of albuterol 48 hours after the final dose.
  • However, albuterol could be detected in nasal swabs for 8 hours after each single dose. In some cases, horses might have detectable levels of albuterol in nasal swabs for several days following the administration of multiple doses.
  • The study made a recommendation for a withdrawal time of 72 hours or longer after administration of aerosol albuterol sulfate to horses before participation in equestrian competitions that regulate for certain performance-enhancing substances.

Limitations

  • The research acknowledged the limitations of its recommendations, as they were based on a small sample of horses and the specific ELISA test used.
  • Furthermore, the study noted that factors specific to individual horses might influence these detection times.

Despite these caveats, this research provides valuable guidelines for administering albuterol to horses in competitive settings. To avoid violating rules around performance-enhancing substances, equine caretakers should consider a buffer period after albuterol administration.

Cite This Article

APA
Dirikolu L, Mollett BA, Troppmann A, Woods WE, Bratton C, Cashman CP, Schroedter D, Mayer B, Lehner AF, Karpiesiuk W, Hughes C, Boyles J, Harkins JD, Tobin T. (2002). Apparent ELISA detection times for albuterol after administration with the torpex equine inhaler device. Vet Ther, 3(3), 297-307.

Publication

ISSN: 1528-3593
NlmUniqueID: 100936368
Country: United States
Language: English
Volume: 3
Issue: 3
Pages: 297-307

Researcher Affiliations

Dirikolu, Levent
  • University of Kentucky, Department of Veterinary Science, Lexington, KY 40546, USA.
Mollett, Brad A
    Troppmann, Amy
      Woods, William E
        Bratton, Calvert
          Cashman, Conor P
            Schroedter, Dwight
              Mayer, Brent
                Lehner, Andreas F
                  Karpiesiuk, Wojciech
                    Hughes, Charlie
                      Boyles, Jeff
                        Harkins, John D
                          Tobin, Thomas

                            MeSH Terms

                            • Administration, Inhalation
                            • Aerosols
                            • Albuterol / administration & dosage
                            • Albuterol / analysis
                            • Albuterol / blood
                            • Albuterol / urine
                            • Animals
                            • Bronchodilator Agents / administration & dosage
                            • Bronchodilator Agents / analysis
                            • Bronchodilator Agents / blood
                            • Bronchodilator Agents / urine
                            • Cross Reactions
                            • Doping in Sports
                            • Drug Administration Schedule
                            • Enzyme-Linked Immunosorbent Assay / methods
                            • Horses
                            • Nebulizers and Vaporizers / veterinary
                            • Reference Standards
                            • Sensitivity and Specificity
                            • Time Factors

                            Citations

                            This article has been cited 0 times.